EGX 30 slips 0.19% as Cleopatra sees 31% Q2 revenue growth
The EGX 30 fell 0.19% to 53,627.3 on July 29, in a session marked by a steady flow of issuer disclosures in Cairo. Cleopatra Hospital said it expects 31% year-on-year revenue growth in the second quarter of 2026, according to TradingView. The market also saw at least 10 regulatory and corporate filings on July 29, including disclosure forms, EGM resolutions, a lawsuit update and financial results from Credit Agricole Egypt, based on EGX releases listed in analyst reports. Outside Egypt, Starcell lost its operating license in Liberia on July 22, Connecting Africa reported.
Related stories
Cairo Stock Exchange — Delta Sugar Jumps 7%, Eastern Tobacco Gains 5.5% in Defensive Rotation
The EGX 30 rose 1.52% on Thursday, October 15, 2026, led by Delta Sugar (+7.0%) and Eastern Company (+5.5%). A weaker pound at 53.38 per dollar and Brent at $105.76 helped drive rotation into defensive and pricing-power names.
EGX 30 rises 1.52% as Elsewedy, Orascom and Abu Qir drive gains
The EGX 30 closed up 1.5157% at 52,273.3 points on October 15, with industrial and fertilizer names underpinning the move. Elsewedy Electric drew attention after a joint venture secured a $2.2 billion EPC contract for the Rabigh 2 IPP expansion in Saudi Arabia, according to IndexBox and Business Insider Africa. Abu Qir Fertilizers reported 86% growth, while Orascom Construction rose 3% on EGP 431.6 million in turnover, according to ad-hoc-news.de and an October 14 analyst note. Emirates NBD Egypt also signed a distribution agreement with EFG Hermes covering 2 equity funds, Arab Finance reported, while Cleopatra Hospital's capital increased to EGP 733.9 million and 5 analysts maintained Outperform ratings, according to ad-hoc-news.de.
Title: Cairo For Investment And Real Estate Developments ?CIRA Education (CIRA.CA) - Disclosure Form for the BoD & the Shareholders' Structure